Institute of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Justus Liebig University Giessen, 35392 Giessen, Germany.
Institute of Medical Virology, National Reference Centre for Hepatitis B Viruses and Hepatitis D Viruses, German Center for Infection Research (DZIF, Partner Site Giessen-Marburg-Langen), Justus Liebig University Giessen, 35392 Giessen, Germany.
Viruses. 2022 Jun 9;14(6):1259. doi: 10.3390/v14061259.
Na/taurocholate cotransporting polypeptide (NTCP, gene symbol SLC10A1) is a hepatic bile acid uptake carrier participating in the enterohepatic circulation of bile acids. Apart from its transporter function, NTCP acts as the high-affinity liver-specific receptor for the hepatitis B virus (HBV), which attaches via its preS1-peptide domain of the large surface protein to NTCP, subsequently leading to endocytosis of the virus/NTCP-receptor complex. Although the process of NTCP-dependent HBV infection of hepatocytes has received much attention over the last decade, the precise molecular sites of the virus/NTCP interaction have not been fully identified. Inspection of the primary protein sequence of human NTCP revealed 139YIYSRGIY146 as a highly conserved tyrosine-rich motif. To study the role of Y139, Y141 and Y146 amino acids in NTCP biology, the aforementioned residues were substituted with alanine, phenylalanine or glutamate (mimicking phosphorylation) using site-directed mutagenesis. Similar to wt NTCP, the Y139A, Y141A, Y146A, Y141F, Y146F, and Y146E mutants were expressed at the plasma membrane of HEK293 cells and exhibited intact bile acid transport function. Y146A, Y146E, and Y146F demonstrated transport kinetics comparable to wild-type NTCP with K values of 57.3-112.4 µM and V values of 6683-7579 pmol/mg protein/min. Only Y141E was transport deficient, most likely due to an intracellular accumulation of the mutant protein. Most importantly, Y146A and Y146E mutation completely abrogated binding of the viral preS1-peptide to NTCP, while the Y146F mutant of NTCP showed some residual binding competence for preS1. Consequently, the NTCP mutants Y146A and Y146E, when expressed in HepG2 hepatoma cells, showed complete loss of susceptibility for in vitro HBV infection. In conclusion, tyrosine 146, and to some extent tyrosine 141, both belonging to the tyrosine-rich motif 139YIYSRGIY146 of human NTCP, are newly identified amino acid residues that play an essential role in the interaction of HBV with its receptor NTCP and, thus, in the process of virus entry into hepatocytes.
钠离子/牛磺胆酸共转运蛋白(NTCP,基因符号 SLC10A1)是一种参与胆汁酸肠肝循环的肝内胆汁酸摄取载体。除了其转运功能外,NTCP 还是乙型肝炎病毒(HBV)的高亲和力肝特异性受体,HBV 通过其大表面蛋白的 preS1-肽结构域与 NTCP 结合,随后导致病毒/NTCP 受体复合物的内吞作用。尽管过去十年中,HBV 依赖 NTCP 感染肝细胞的过程受到了广泛关注,但病毒/NTCP 相互作用的确切分子位点尚未完全确定。对人 NTCP 的一级蛋白序列进行检查显示,139YIYSRGIY146 是一个高度保守的酪氨酸丰富基序。为了研究 Y139、Y141 和 Y146 氨基酸在 NTCP 生物学中的作用,使用定点突变将上述残基分别突变为丙氨酸、苯丙氨酸或谷氨酸(模拟磷酸化)。与 wt NTCP 相似,Y139A、Y141A、Y146A、Y141F、Y146F 和 Y146E 突变体在 HEK293 细胞的质膜上表达,并表现出完整的胆汁酸转运功能。Y146A、Y146E 和 Y146F 显示出与野生型 NTCP 相当的转运动力学,K 值为 57.3-112.4 μM,V 值为 6683-7579 pmol/mg 蛋白/min。只有 Y141E 是转运缺陷型,很可能是由于突变蛋白的细胞内积累。最重要的是,Y146A 和 Y146E 突变完全阻断了病毒 preS1-肽与 NTCP 的结合,而 NTCP 的 Y146F 突变体对 preS1 仍具有一定的结合能力。因此,当在 HepG2 肝癌细胞中表达时,NTCP 突变体 Y146A 和 Y146E 完全丧失了对体外 HBV 感染的易感性。总之,酪氨酸 146,在某种程度上还有酪氨酸 141,它们都属于人 NTCP 的 139YIYSRGIY146 酪氨酸丰富基序,是新发现的氨基酸残基,在 HBV 与其受体 NTCP 的相互作用中发挥着重要作用,从而在病毒进入肝细胞的过程中发挥着重要作用。